Novo Nordisk expands discounted Wegovy to all cash-paying U.S. customers

Novo Nordisk expands discounted Wegovy to all cash-paying U.S. customers


Jakub Porzycki | Nurphoto | Getty Images

Novo Nordisk said on Monday all eligible cash-paying customers in the United States can buy its weight-loss drug Wegovy at a discounted price of $499 per month at their local pharmacy.

U.S.-listed shares of Novo fell more than 2.5% to $74.92 in premarket trading. Novo has also lost its spot as Europe’s largest company to German software firm SAP having underperformed the market in recent months.

The Danish drugmaker and rival Eli Lilly have begun offering their popular weight-loss drugs at discounted prices, as they grapple with shifts to the competitive dynamic of the highly lucrative obesity drug market.

Investors have been worried about growing competition with Lilly as well as disappointing data from its next-generation weight-loss candidate CagriSema, which Novo hopes will be a powerful successor to Wegovy.

Last month, Lilly cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range of doses sold online to try to stave off competition.

Compounding pharmacies have been selling hundreds of thousands of doses of copies of Wegovy while it was in shortage. The Food and Drug Administration has since asked them to cease making copies but will hold off on taking action until a federal court delivers its ruling in a lawsuit.

Wegovy can cost more than $1,000 per month for those who do not have health insurance coverage. The high costs had been widely criticized by former President Joe Biden and U.S. Senator Bernie Sanders, among others.

Until now, the drug was only available at the discounted price through its NovoCare Pharmacy program.

The expanded program will offer all dosage strengths of the drug to uninsured patients or eligible patients with commercial insurance who do not have coverage for obesity medicines.

This replaces Novo’s previous program through which it offered month’s supply of Wegovy for $650.



Source

Amazon Kuiper second satellite launch postponed by ULA due to rocket booster issue
World

Amazon Kuiper second satellite launch postponed by ULA due to rocket booster issue

A United Launch Alliance Atlas V rocket is shown on its launch pad carrying Amazon’s Project Kuiper internet network satellites as the vehicle is prepared for launch at the Cape Canaveral Space Force Station in Cape Canaveral, Florida, U.S., April 28, 2025. Steve Nesius | Reuters United Launch Alliance on Monday was forced to delay […]

Read More
Justin Sun’s Tron to go public through reverse merger in deal led by Trump-linked bank
World

Justin Sun’s Tron to go public through reverse merger in deal led by Trump-linked bank

Justin Sun, founder of blockchain platform Tron, poses for a photograph in Hong Kong, May 8, 2020. Calvin Sit | Bloomberg | Getty Images Justin Sun’s crypto company Tron is set to hit the public market through a reverse merger with a manufacturer of custom toys and souvenirs for the world’s biggest theme parks. SRM […]

Read More
Citi recommends these rare stocks that will show profitability gains this year
World

Citi recommends these rare stocks that will show profitability gains this year

Quality companies with strong returns are getting harder to find, according to Citi Research. Return on equity, considered to be a profitability metric calculated by dividing a company’s net income by shareholders’ equity, is “increasingly scarce” among big-name stocks now, Citi U.S. equity strategist Scott Chronert wrote in a recent note to clients. “Stocks where […]

Read More